Journals / Çocuk Dergisi / 2005 / Cilt: 5 - Sayı: 3

Use of tumour markers in clinical pediatric oncology

Pediatrik onkolojide tümör belirteçlerinin klinikteki yeri

Pages
162–165
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This rewiew is planned to determine the tumour markers that are useful and meaningful in pediatric oncology and to avoid unnecessary tests and wrong interpretations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tumour markers are used frequently in diagnosis, prognostic evaluation and follow up in oncology.
📊
Key Findings & Data:They are used widely in adults but their use is limited and their specificity and sensitivity are low in pediatric tumour types.
💡
Conclusion & Impact:This rewiew is planned to determine the tumour markers that are useful and meaningful in pediatric oncology and to avoid unnecessary tests and wrong interpretations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pediatri · Tümör belirteci · biyolojik

Abstract

Tumour markers are used frequently in diagnosis, prognostic evaluation and follow up in oncology. They are used widely in adults but their use is limited and their specificity and sensitivity are low in pediatric tumour types. This rewiew is planned to determine the tumour markers that are useful and meaningful in pediatric oncology and to avoid unnecessary tests and wrong interpretations.

Özet

Tümör belirteçleri onkolojide gerek tanı, gerek prognoz ve gerekse izlemde sıklıkla kullanılır. Erişkinde kullanım alanları oldukça geniş olmasına karşın pediatride kullanılabildikleri tümör tipleri sınırlı olup, özgüllük ve duyarlılıkları da düşüktür. Bu derleme, pediatrik onkolojide klinik olarak kullanımı uygun ve anlamlı olan tümör belirteçlerini güncel bilgiler ışığında vurgulayarak gereksiz tetkiklerin ya da yanlış yorumların yapılmasını engellemek amacıyla yapılmıştır.

🔖

Cite This Article

TOKUÇ, G., ÖKTEM, S., KETENCİ, Ö. (2005). Use of tumour markers in clinical pediatric oncology. Çocuk Dergisi, Cilt: 5 - Sayı: 3, 162–165. https://ajindex.com/articles/189558

References (15)

  1. Kellie SJ. Serum markers in tumor diagnosis and treatment. In: Pinkerton CR and Plowman PN, eds. Paediatric Oncology. 2nd ed. Chapman&Hall Medical, 1997: 189-219. 2.Perkins GL, Slater ED, Sanders GK, Prichard JG. Serum tumor markers. Am Fam Physician 2003
  2. : 1075-82. 3.Labdenne P, Heikinheimo M. Clinical use of tumor markers in childhood malignancies. Ann Med 2002
  3. Massacesi C, Rocchi MB, Marcucci F, Pilone A, Galeazzi M, Bonsignori M. Serum tumor markers may precede instrumental response to chemotherapy in patients with metastatic cancer. Int J Biol Markers. 2003
  4. Rye PD, Nustad K, Stigbrand T. Tumor marker workshop. Tumour Biol 2003
  5. Kashyap R, Jain A, Nalesnik M, et al. Clinical significance of elevated alpha-fetoprotein in adults and children. Dig Dis Sci 2001
  6. Sayar D, Yaniv I, Goshen Y, Cohen IJ. Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept. Pediatr Hematol Oncol 2001
  7. Abbasoglu L, Gun F, Tansu Salman F, et al. Hepatoblastoma in children. Acta Chir Belg 2004
  8. Veeramachaneni R, Herrera GA, Turbat-Herrera EA. Hepatoblastoma in a 15-month-old male: cytomorphology, electron microscopy, and differential diagnosis. Ultrastruct Pathol 2003
  9. Tsai JF, Jeng JE, Chuang LY, et al. Serum insulin-like growth factor-II.and alpha-fetoprotein as tumor markers of hepatocellular carcinoma. Tumour Biol 2003
  10. Mc Intire KR, Waldmann TA, Moertel CG, Go VLW. Serum. a-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975
  11. Bloomer JR, Waldmann TA, Mclntire KR, Klatskin G. a Fetoprotein in non-neoplastic hepatic disorders. J Am Med Assoc 1975
  12. Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv 2003
  13. Hu KQ, Kyulo NL, Lim N, et al. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with cronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 2004
  14. Mann JR, Lakin GE, Leonard JC, et al. Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumors. Arch Dis Child 1978
  15. Melia WM, Johnson PJ, Carter S, et al. Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma. Cancer 1981